Traded Jan 5 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Dec 17, 2025 · Filed Dec 18, 2025
A Hims & Hers Health director sold $368K of Hims & Hers Health shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$367,871
Shares × reported transaction price
44 days after results of Nov 3, 2025, 68 days before results of Feb 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.5% | +1.4% | −5.0% |
| 30 days | −14.3% | −0.4% | −13.9% |
| 90 days | −32.1% | −3.0% | −29.0% |
| 180 days | −10.3% | +8.9% | −19.2% |
Past results only. Not a forecast.
Traded Jan 5 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Jan 5 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Oluyemi Okupe (Chief Financial Officer) sold ~$306K of Hims & Hers Health
Scheduled in advance